PhaseBio Pharmaceuticals Inc Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Acknowledgement of Grant of a Sublicense in Accordance with the License Agreement between Medimmune Limited and PhaseBio Pharmaceuticals, Inc. and Related Options
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
DE
2021
License Agreement, dated as of June 16, 2021, by and between PhaseBio Pharmaceuticals, Inc. and Alfasigma, S.p.A
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
PA
2021
Amendment to License Agreement, dated January 9, 2020, by and between PhaseBio Pharmaceuticals, Inc. and MedImmune Limited
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
2020
License Agreement, dated April 1, 2019, by and between PhaseBio Pharmaceuticals, Inc. and Wacker Biotech GmbH
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
2019
Eighth Amendment to License Agreement, dated as of March 5, 2019, by and between PhaseBio Pharmaceuticals, Inc. and Duke University
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
2019
License Agreement, dated as of November 21, 2017, by and between the Registrant and Medimmune Limited
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
NY
2018
License Agreement, dated as of October 18, 2006 and as amended to date, by and between Phase Bioscience, Inc. (predecessor in interest to the Registrant) and Duke University
License Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
NC
2018